TABLE 2.
DH (N = 40) vs RVO (N = 25) |
DH (N = 40) vs MA (N = 14) |
MA (N = 14) vs RVO (N = 25) |
|||||||
---|---|---|---|---|---|---|---|---|---|
Adjusted R2 | Beta Estimate (Standard Error) |
P Value | Adjusted R2 |
Beta Estimate (Standard Error) |
P
Value |
Adjusted R2 |
Beta Estimate (Standard Error) |
P Value | |
ΔA Predictors | |||||||||
Age | 0.29 | −0.2 (0.09) | .12 | 0.033 | −0.001 (0.09) | .99 | 0.30 | 0.04 (0.1) | .71 |
Sex (male as referent) | −2.8 (2.1) | .19 | −0.4 (2.9) | .89 | −5.6 (2.6) | .041 | |||
Hypertension (no as referent) | 0.7 (2.1) | .75 | 3.2 (2.4) | .19 | 1.4 (2.6) | .60 | |||
Diabetes mellitus (no as referent) | −6.8 (2.6) | .011 | −6.4 (2.8) | .026 | −3.5 (3.0) | .26 | |||
Using blood thinning medication (no as referent) | 1.6 (2.1) | .46 | 0.2 (2.2) | .92 | 0.7 (2.8) | .81 | |||
Subject typea | −6.6 (2.0) | .0013 | 1.9 (2.4) | .43 | −7.5 (2.6) | .0077 | |||
ΔV Predictors | |||||||||
Age | 0.39 | 0.04 (0.09) | .70 | 0.10 | 0.003 (0.08) | .97 | 0.50 | 0.07 (0.08) | .39 |
Sex (male as referent) | −2.5 (2.1) | .25 | −2.2 (2.8) | .43 | −3.3 (2.2) | .14 | |||
Hypertension (no as referent) | 0.9 (2.1) | .67 | 3.4 (2.3) | .15 | −1.3 (2.2) | .55 | |||
Diabetes mellitus (no as referent) | −6.9 (2.6) | .012 | −7.7 (2.7) | .0066 | −2.7 (2.5) | .29 | |||
Using blood thinning medication (no as referent) | 0.3 (2.1) | .89 | −0.4 (2.1) | .84 | −1.2 (2.4) | .63 | |||
Subject typea | −10.3 (2.0) | <.0001 | 1.3 (2.4) | .60 | −11.3(2.2) | <.0001 |
DH = disc hemorrhage; MA = macroaneurysm; RVO = retinal vein occlusion.
In DH vs RVO comparison, RVO is the reference group. In DH vs MA comparison, MA is the reference group. In MA vs RVO comparison, RVO is the reference group.